Life Sciences Times

AstraZeneca Names Rick R. Suarez US President and Head of US BioPharmaceuticals Unit

Parabilis Medicines Raises $305 Million to Advance Zolucatetide and Helicon Platform

Tubulis Names Charles Fuchs, M.D. as Chief Medical Officer to Lead Clinical Strategy

Cellino and Polyphron Partner to Scale Personalized Tissue Replacement Manufacturing

BostonGene Partners With Ottimo Pharma to Advance AI-Guided Development of PD-1/VEGFR2 Cancer Therapy

Vizgen Raises $48 Million to Accelerate Spatial Multi-Omics Growth

Charles River Laboratories Names Birgit Girshick as Next CEO as James C. Foster Plans Retirement

International Institute of New England Honors Alnylam CEO Dr. Yvonne Greenstreet With 2026 Golden Door Award

Fraser Health Cuts Discharge Documentation Time with MEDITECH AI Tool

Corsera Health Raises $80 Million Series A and Begins First Clinical Trial